Roche Holding AG

RHHBY

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    103,249

Roche Holding AG News & Analysis

stocks

10 best US blue-chip stocks to buy for the long term

The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks

The 10 best global companies to invest in now

These undervalued stocks of high-quality companies are attractive investments today.
stocks

5 top US dividend shares from the best managers

These cheap dividend stocks are popular among highly rated concentrated fund managers.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,071.409.10-0.10%
CAC 407,802.3040.980.53%
DAX 4023,647.0014.050.06%
Dow JONES (US)45,490.92220.42-0.48%
FTSE 1009,270.2244.830.49%
HKSE26,106.0194.25-0.36%
NASDAQ21,886.066.570.03%
Nikkei 22544,372.50534.831.22%
NZX 50 Index13,229.1547.09-0.35%
S&P 5006,532.0419.430.30%
S&P/ASX 2008,805.008.80-0.10%
SSE Composite Index3,875.3163.091.65%

Market Movers